These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33385827)

  • 1. Timing of plasma exchange for neuromyelitis optica spectrum disorders: A meta-analysis.
    Huang X; Wu J; Xiao Y; Zhang Y
    Mult Scler Relat Disord; 2021 Feb; 48():102709. PubMed ID: 33385827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis.
    Siritho S; Nopsopon T; Pongpirul K
    J Neurol; 2021 Dec; 268(12):4549-4562. PubMed ID: 33037886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of plasma exchange treatment in children with AQP4-IgG positive neuromyelitis optica spectrum disorder.
    Li Z; Wan L; Liu X; Wang J; Shi X; Zhou H; Xu Q; Wei S; Yang G
    Front Immunol; 2022; 13():1113406. PubMed ID: 36685590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of plasma exchange in acute attacks of neuromyelitis optica spectrum disorders: A systematic review and meta-analysis.
    Yu HH; Qin C; Zhang SQ; Chen B; Ma X; Tao R; Chen M; Chu YH; Bu BT; Tian DS
    J Neuroimmunol; 2020 Nov; 350():577449. PubMed ID: 33227661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders: A Systematic Review and Meta-analysis.
    Damato V; Evoli A; Iorio R
    JAMA Neurol; 2016 Nov; 73(11):1342-1348. PubMed ID: 27668357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Exchange for Neuromyelitis Optica Spectrum Disorders in Chinese Patients and Factors Predictive of Short-term Outcome.
    Jiao Y; Cui L; Zhang W; Zhang Y; Wang W; Zhang L; Tang W; Jiao J
    Clin Ther; 2018 Apr; 40(4):603-612. PubMed ID: 29606515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential intermittent therapeutic plasma exchange: A possible induction and maintenance therapy in the management of adult patients with neuromyelitis optica spectrum disorder.
    Viswanathan S; Schee JP; Omar MA; Hiew FL
    Ther Apher Dial; 2021 Aug; 25(4):513-532. PubMed ID: 33029928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
    Aungsumart S; Apiwattanakul M
    Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX.
    Songthammawat T; Srisupa-Olan T; Siritho S; Kittisares K; Jitprapaikulsan J; Sathukitchai C; Prayoonwiwat N
    Mult Scler Relat Disord; 2020 Feb; 38():101506. PubMed ID: 31731214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis on efficacy and safety of rituximab for neuromyelitis optica spectrum disorders.
    Dong GY; Meng YH; Xiao XJ
    Medicine (Baltimore); 2022 Sep; 101(36):e30347. PubMed ID: 36086713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of rituximab in the treatment of neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
    Wang Y; Chang H; Zhang X; Yin L
    Mult Scler Relat Disord; 2021 May; 50():102843. PubMed ID: 33609924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.
    Llufriu S; Castillo J; Blanco Y; Ramió-Torrentà L; Río J; Vallès M; Lozano M; Castellà MD; Calabia J; Horga A; Graus F; Montalban X; Saiz A
    Neurology; 2009 Sep; 73(12):949-53. PubMed ID: 19770470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
    Abboud H; Petrak A; Mealy M; Sasidharan S; Siddique L; Levy M
    Mult Scler; 2016 Feb; 22(2):185-92. PubMed ID: 25921047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children.
    Manguinao M; Krysko KM; Maddike S; Rutatangwa A; Francisco C; Hart J; Chong J; Graves JS; Waubant E
    Mult Scler Relat Disord; 2019 Oct; 35():50-54. PubMed ID: 31319355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of plasma exchange in neuromyelitis optica spectrum disorder: A systematic review and meta-analysis.
    Kosiyakul P; Songwisit S; Ungprasert P; Siritho S; Prayoonwiwat N; Jitprapaikulsan J
    Ann Clin Transl Neurol; 2020 Nov; 7(11):2094-2102. PubMed ID: 32956562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders.
    Bonnan M; Valentino R; Debeugny S; Merle H; Fergé JL; Mehdaoui H; Cabre P
    J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):346-351. PubMed ID: 29030418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of apheresis therapy in AQP4 antibody-positive NMOSD attack: A propensity score-matched cohort study.
    Xu Y; Wang H; Song T; Yin L; Yao Y; Wei Y; Cong H; Sun J; Zhang X; Tian DC
    CNS Neurosci Ther; 2024 May; 30(5):e14780. PubMed ID: 38790106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma exchange: an effective add-on treatment of optic neuritis in neuromyelitis optica spectrum disorders.
    Song W; Qu Y; Huang X
    Int Ophthalmol; 2019 Nov; 39(11):2477-2483. PubMed ID: 30825049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica.
    Merle H; Olindo S; Jeannin S; Valentino R; Mehdaoui H; Cabot F; Donnio A; Hage R; Richer R; Smadja D; Cabre P
    Arch Ophthalmol; 2012 Jul; 130(7):858-62. PubMed ID: 22776923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoadsorption or plasma exchange in steroid-refractory multiple sclerosis and neuromyelitis optica.
    Lipphardt M; Mühlhausen J; Kitze B; Heigl F; Mauch E; Helms HJ; Müller GA; Koziolek MJ
    J Clin Apher; 2019 Aug; 34(4):381-391. PubMed ID: 30698295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.